Anesthesia for a Patient on Monoamine Oxidase Inhibitors

Monoamine oxidase (MAO) inhibitors are frequently used for multidrug-resistant major depression, which is emerging as an epidemic in the modern era. Anesthesia during chronic use of MAO inhibitors is a matter of debate because of increased risk of drug interactions with various anesthetic drugs. Cardiac disorders contribute to perioperative and postoperative complications. Recent studies illustrate the safety of anesthesia without discontinuation of MAO inhibitors if sympathetic homeostasis is maintained and known drug interactions are avoided. In this case study, a 72-year-old male psychiatric patient on permanent treatment with tranylcypromine (30 mg/ day) was admitted for bipolar hemiarthroplasty. After complete aseptic precautions, spinal anesthesia was achieved by 12.5 mg 0.5% heavy bupivacaine and 30 μg clonidine intrathecally. The anesthetic effect was adequate, but surgery was not completed timely and the effect of spinal anesthesia was weaned off, so general anesthesia was given and surgery was completed. There was no perioperative or postoperative complication. In conclusion, general or regional anesthesia for noncardiac surgery without discontinuation of MAO inhibitors may be safe after careful preoperative evaluation of the patient.

[1]  C. Kalkman,et al.  Antidepressive treatment with monoamine oxidase inhibitors and the occurrence of intraoperative hemodynamic events: a retrospective observational cohort study. , 2012, The Journal of clinical psychiatry.

[2]  J. Miners,et al.  An evaluation of potential mechanism-based inactivation of human drug metabolizing cytochromes P450 by monoamine oxidase inhibitors, including isoniazid. , 2006, British journal of clinical pharmacology.

[3]  K. Audenaert,et al.  Anaesthesia for patients with mood disorders , 2005, Current opinion in anaesthesiology.

[4]  R. W. Simpson,et al.  Discontinuation and reinstitution of medications during the perioperative period. , 2004, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[5]  G. Baker,et al.  Inhibitory Effects of the Monoamine Oxidase Inhibitor Tranylcypromine on the Cytochrome P450 Enzymes CYP2C19, CYP2C9, and CYP2D6 , 2004, Cellular and Molecular Neurobiology.

[6]  C. Scher,et al.  The Self- Reporting of Psychiatric Medications in Patients Scheduled for Elective Surgery , 1998 .

[7]  J. Sprung,et al.  Cardiovascular collapse during anesthesia in a patient with preoperatively discontinued chronic MAO inhibitor therapy. , 1997, Journal of clinical anesthesia.

[8]  C. Orlikowski,et al.  Epidural anaesthesia, ephedrine and phenylephrine in a patient taking moclobemide, a new monoamine oxidase inhibitor , 1996, Anaesthesia.

[9]  S. Fishman,et al.  Acute exacerbation of depression after discontinuation of monoamine oxidase inhibitor prior to cardiac surgery. , 1996, Anesthesia and analgesia.

[10]  M. Douglas,et al.  Anaesthetic management of labour and delivery in a woman taking long-term MAOI , 1995, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[11]  R. Savage,et al.  Cardiac surgery in a patient taking monoamine oxidase inhibitors: an adverse fentanyl reaction. , 1994, Anesthesia and analgesia.

[12]  A. Baker,et al.  MAO inhibitors and coronary artery surgery: a patient death , 1992, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[13]  A. Mortimer,et al.  Safe use of propofol in a patient receiving tranylcypromine , 1991, Anaesthesia.

[14]  S. Linter,et al.  Monoamine oxidase inhibitors and anaesthesia. A review. , 1988, British journal of anaesthesia.

[15]  R. McCarthy,et al.  Monoamine Oxidase Inhibitors: Should They Be Discontinued Preoperatively? , 1985, Anesthesia and analgesia.

[16]  D. J. Blomley MONOAMINE-OXIDASE INHIBITORS. , 1964, Lancet.

[17]  J. Slaets,et al.  Psychotropic drugs and the perioperative period: a proposal for a guideline in elective surgery. , 2006, Psychosomatics.

[18]  D. Touw,et al.  [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases]. , 2003, Nederlandsch tijdschrift voor geneeskunde.